Promising New Malaria Vaccination Success

Scientists have long hoped to find a malaria vaccine, given the positive results obtained from clinical trials. Now they succeed.

Malaria, one of the most deadly diseases in the world has been transmitted to 219 million people by 2010. Scientists have long hoped to find a vaccine.
Thursday ( 08.09.13 ) a number of U.S. researchers announced success in the scientific journal Science , a small explanation of the success of an experiment that is still in the early clinical stages .


" A lot of people say , this is something that is not possible . , But the proof , " said Judith Epstein , a malaria researcher , in an interview with Reuters news agency . " Now we are in the first stage to actually be able to find an effective vaccination , " he said .
Successful experiment
The vaccine was manufactured company Sanaria Incorporated of Maryland , USA . Clinical trial conducted between October 2011 and October 2012 . Those who participate , both are vaccinated and who is not , got five bites of mosquitoes infected with malaria . Studies show that the higher the dose given to a person , the less likely malaria develops in that person 's body .
According to Drs . Anthony Fauci , director of the research institute of allergy and infectious diseases ( NIAID ) , the results of these experiments are the most promising of all malaria vaccination during the trial .
But Fauci hesitate to call it a breakthrough experimental results, noting that only a small number of people participate in the experiment. 57 healthy people who follow the research.

Can be Expected But Not Surely

Fauci also said that it was unclear how long the vaccination can keep people from contracting malaria. The vaccine, called PfSPZ made ​​of Plasmodium falciparum parasite species live, attenuated strength. The parasite is the most lethal of all malaria-causing parasite. 
There are still a lot of work and research is needed before the vaccine could be disseminated to the public needs. But these early results promising success. "There are still some steps that should be taken, before researchers can feel calm because I have something that might be ready for the first extended time," said Fauci explained. "So we have not fully get there., But the result is heartening to keep trying," he added.

Lead researcher Sanaria Incorporated company, Stephen Hoffman, who also wrote the study with Robert Seder of NIAID, estimates, are still required four years before the vaccine can be obtained by the public at large. There is currently no vaccine against malaria that can be purchased on the open market.